首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Simultaneous quantification of fifteen compounds in rat plasma by LC-MS/MS and its application to a pharmacokinetic study of Chaihu-Guizhi decoction
【24h】

Simultaneous quantification of fifteen compounds in rat plasma by LC-MS/MS and its application to a pharmacokinetic study of Chaihu-Guizhi decoction

机译:LC-MS / MS同时定量大鼠等离子体中的十五种化合物及其在柴胡 - 桂芝汤的药代动力学研究中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

A simple, sensitive and selective high-performance liquid chromatography electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS) method was developed and validated for simultaneous determination and pharmacokinetic study of 15 active compounds (Saikosaponin A, Baicalin, Wogonin, Glycyrrhizic acid, Glycyrrhetinic acid, Albiflorin, Paeoniflorin, Liquiritin, Isoliquiritin, Liquiritigenin, Isoliquiritigenin, Cinnamic acid, Gallic acid, Wogonoside and Oroxylin A) in rat plasma. After a feasible protein precipitation using methanol for sample preparation, chromatographic separation was carried out with a Halo (R) C-18 column (2.1 x 100 mm, 2.7 mu m) at 35 degrees C, water containing 0.1% formic acid and acetonitrile were used as the mobile phase with a flow rate of 0.3 mL/min. Multiple reaction monitoring (MRM) with positive and negative ion switching mode was performed for the quantification of the standards and internal standard in plasma. All the calibration curves showed good linear regression within the linear range (r(2) 0.9923). In particular, the results of the method validation including specificity, linearity, accuracy, precision, extraction recovery, matrix effect, and stability of compounds in bio-samples were all within the current acceptance criteria. The established method was successfully applied to the pharmacokinetic study of 15 compounds in rats after oral administration of CGD and laid the foundation for studying the active components and mechanism of CGD in vivo.
机译:简单,灵敏和选择性高效液相色谱电喷雾电离串联质谱(HPLC-ESI-MS / MS)方法,并验证了15个活性化合物的同时测定和药代动力学研究(Saikosaponin A,Baicalin,Wogonin,Glycyrrhizic acid ,甘草酸,阿联金,芍药蛋白,液体素,伊索里替林,液中素,孤立因素,肉桂酸,肉桂酸,无食子酸,WOGONONIDES和氧氧基脲A)在大鼠血浆中。在使用甲醇用于样品制备的可行蛋白质沉淀后,用卤素(R)C-18柱(2.1×100mm,2.7μm)在35℃下进行色谱分离,含有0.1%甲酸和乙腈的水用作流动阶段,流速为0.3ml / min。对具有正和负离子切换模式的多重反应监测(MRM)进行血浆中标准和内标的量化。所有校准曲线在线性范围内显示出良好的线性回归(R(2)& 0.9923)。特别地,方法验证的结果包括特异性,线性度,准确性,精度,提取恢复,基质效应以及生物样本中化合物的稳定性全部在当前验收标准中。成熟的方法已成功应用于口服CGD后大鼠15种化合物的药代动力学研究,并为研究CGD的活性成分和机制奠定了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号